Meropenem Sun

Meropenem, the active ingredient in Meropenem Sun, is a carbapenem antibiotic presented as an injectable solution for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, nosocomial pneumonia, meningitis, and septicemia in hospitalized patients.

GNH USA supplies Meropenem Sun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Meropenem is a broad‑spectrum carbapenem antibiotic used for serious bacterial infections.

- Complicated intra‑abdominal infections: provides rapid bacterial eradication in severe abdominal sepsis. - Complicated urinary tract infections: eliminates resistant uropathogens causing upper urinary tract disease. - Nosocomial pneumonia: treats hospital‑acquired lung infections resistant to other beta‑lactams. - Meningitis: penetrates the cerebrospinal fluid to clear central nervous system infections. - Septicemia: offers bactericidal activity in bloodstream infections caused by Gram‑negative and Gram‑positive organisms.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be watery and self‑limiting. - Headache: transient and usually resolves. - Infusion site reactions: erythema or phlebitis at the injection site. - Elevated liver enzymes: transient increases in ALT/AST. - Rash: non‑specific skin eruption.

Serious or Rare Side Effects: - Seizures: especially in patients with renal impairment or CNS disorders. - Anaphylaxis: acute, potentially life‑threatening hypersensitivity. - Clostridioides difficile colitis: severe diarrhea due to gut flora disruption. - Severe neutropenia: marked reduction in white blood cells. - Renal toxicity: acute kidney injury in susceptible individuals. - Hepatic failure: rare but serious liver dysfunction.

Careful assessment and monitoring are required before and during therapy. - Renal function: adjust dose in patients with impaired clearance. - Allergy: avoid in individuals with known carbapenem hypersensitivity. - Seizure risk: monitor patients with a history of CNS disorders. - Pregnancy: use only when the potential benefit justifies the potential risk. - Drug interactions: review concomitant medications for possible interactions. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with several medicines, requiring attention to severity.

Major Interactions (Avoid): - Valproic acid: may reduce serum levels, risking seizure breakthrough. - Probenecid: can increase meropenem concentrations, heightening toxicity. - Aminoglycosides: combined nephrotoxic potential. - Loop diuretics: additive renal impairment risk. - Warfarin: possible enhancement of anticoagulant effect.

Moderate Interactions (Monitor Closely): - Other antibiotics: additive neurotoxicity, especially with quinolones. - NSAIDs: monitor renal function when used together. - Anticonvulsants: may require dose adjustments for seizure control.